BiotechTube
Home/Rezq Bio/Doug Greene, MD
DG

Doug Greene, MD

Head of R&D

Rezq Bio

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesType 1 Diabetes

Rezq Bio Pipeline

DrugIndicationPhase
RZQ-MC1Early Onset Type 1 DiabetesPhase 1B/2A
RZQ-MC2Colitis/IBDPreclinical
RZQ-CC1Transplant/Implant SupportPreclinical
RZQ-MM*Type 1 DiabetesPreclinical

Leadership Team at Rezq Bio

AH
Arjun Hattiangadi
CEO and Founder
NG
Nick Giannoukakis, PhD
CSO and Founder
HF
Howard Foyt, MD, PhD
CMO
EL
Elina Linetsky, PhD
VP of Process, Development and Manufacturing
View full Rezq Bio profile